These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10762435)

  • 1. Evaluation of the ability of levonorgestrel butanoate alone, or in combination with testosterone buciclate, to suppress spermatogenesis in the bonnet monkey (Macaca radiata).
    Rajalakshmi M; Pal PC; Jeyaraj DA; Sharma RS; Griffin PD; Waites GM
    Int J Androl; 2000 Apr; 23(2):95-105. PubMed ID: 10762435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of levonorgestrel butanoate alone and in combination with testosterone buciclate on spermatogenesis in the bonnet monkey.
    Sharma RS; Pal PC; Griffin PD; Waites GM; Rajalakshmi M
    Andrologia; 2007 Aug; 39(4):117-23. PubMed ID: 17683459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-human primate study (baboon; Papio hamadryas) to determine if a long-acting progestogen, levonorgestrel butanoate, combined with a long-acting androgen, testosterone buciclate, can suppress spermatogenesis: I. Dose-finding study.
    Goncharov NP; Katzia GV; Butnev VU; Richkor EG; Matikainen T; Waites GM
    Int J Androl; 1995 Apr; 18(2):75-82. PubMed ID: 7665213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-human primate study (baboon; Papio hamadryas) to determine if a long-acting progestogen, levonorgestrel butanoate, combined with a long-acting androgen, testosterone buciclate, can suppress spermatogenesis: II. Efficacy study.
    Goncharov NP; Katzia GV; Butnev VU; Gorlushkin VM; Waites GM
    Int J Androl; 1995 Apr; 18(2):83-7. PubMed ID: 7665214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of testosterone buciclate on testicular and epididymal sperm functions in bonnet monkeys (Macaca radiata).
    Kinger S; Pal PC; Rajalakshmi M; Kumar PK; Sharma DN; Bajaj JS
    Contraception; 1995 Aug; 52(2):121-7. PubMed ID: 8536449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of efficacy, safety, and reversibility of combination regimen of cyproterone acetate and testosterone buciclate in bonnet monkey.
    Sharma RS; Rajalakshmi M; Pal PC; Roy S; Behal VK; Sharma DN; Chaturvedi PK; Pruthi JS
    Contraception; 2000 Oct; 62(4):195-201. PubMed ID: 11137074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of testicular and epididymal functions in a non-human primate (bonnet monkey) by combined administration of a gonadotropin-releasing hormone antagonist and testosterone buciclate.
    Rajalakshmi M; Kumar PK; Kinger S; Pal PC; Pruthi JS; Bajaj JS
    Contraception; 1995 Dec; 52(6):381-8. PubMed ID: 8749603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial with levo-norgestrel and testosterone oenanthate for male fertility control.
    Føgh M; Corker CS; McLean H; Hunter WM; Petersen IB; Philip J; Schou G; Skakkebaek NE
    Acta Endocrinol (Copenh); 1980 Oct; 95(2):251-7. PubMed ID: 6776755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in chinese men.
    Gui YL; He CH; Amory JK; Bremner WJ; Zheng EX; Yang J; Yang PJ; Gao ES
    J Androl; 2004; 25(5):720-7. PubMed ID: 15292101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
    Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
    J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
    Mann DR; Gould KG; Smith MM; Duffey T; Collins DC
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone-induced inhibition of spermatogenesis is more closely related to suppression of FSH than to testicular androgen levels in the cynomolgus monkey model (Macaca fascicularis).
    Weinbauer GF; Schlatt S; Walter V; Nieschlag E
    J Endocrinol; 2001 Jan; 168(1):25-38. PubMed ID: 11139767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
    Kamischke A; Venherm S; Plöger D; von Eckardstein S; Nieschlag E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.
    Kamischke A; Plöger D; Venherm S; von Eckardstein S; von Eckardstein A; Nieschlag E
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):43-52. PubMed ID: 10931079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of spermatogenesis by testosterone enanthate in Thai men.
    Aribarg A; Sukcharoen N; Chanprasit Y; Ngeamvijawat J; Kriangsinyos R
    J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.